Researchers discover new option to target the metastatic capacity of melanoma cells

Roche’s com­pe­ti­tion in the eye dis­ease space is in­ten­si­fy­ing with Re­gen­eron’s high-dose Eylea and a loom­ing biosim­i­lar chal­lenge, but the Swiss phar­ma said its block­buster

A for­mer Alex­ion ex­ec­u­tive con­fessed to in­sid­er trad­ing by shar­ing con­fi­den­tial com­pa­ny in­for­ma­tion in 2020 dur­ing a crim­i­nal hear­ing at a New York fed­er­al court